期刊文献+

Galectin-3基因多态性与颅底脊索瘤易感性关联分析 被引量:2

Study of Galectin - 3 gene a allele as a genetic predisposition factor for skull base chordoma
原文传递
导出
摘要 目的探讨Galectin-3基因多态性与颅底脊索瘤发病风险的关联。方法运用PCR和直接测序法对5l例颅底脊索瘤患者和102例健康人的Galectin-3基因中rs4644、rs4652位点进行基因分型,比较颅底脊索瘤患者与健康人之间Galectin-3基因中rs4644、rs4652位点基因型、等位基因频率分布的差异,并根据性别、年龄进行分层分析。结果Galectin-3基因中rs4652位点基因型在颅底脊索瘤组和对照组之间分布差异有统计学意义(P=0.046)。按性别分层,在女性群体中,rs4652位点基因型在颅底脊索瘤组和对照组之间分布差异有统计学意义(共显性模型,CC/AC/AA,P=0.020;显性模型,CC+AC/AA,P=0.009),携带CC和AC基因型的群体患颅底脊索瘤的发病风险增加(OR=4.5;95%CI=1.365~14.833)。结论Galectin-3基因中rs4652位点基因多态性与颅底脊索瘤发病风险相关联,在女性群体中,携带CC和AC基因型者患颅底脊索瘤的风险增高。 Objective To investigate the association of single nucleotide polymorphisms in Galectin -3 gene and the susceptibility of skull base chordomas in Chinese. Methods Two candidate genetic variants (rs4644 and rs4652)in Galectin -3 gene were chosen based on the previous study. The distribution of genotype and allele were investigated in 51 patients with skull base chordomas and 102 healthy subjects. The genomic DNA was prepared from peripheral blood leukocytes of the subjects. Polymerase chain reaction and the following sequencing were performed for genotyping. Statistical analysis was performed using the SPSS software (IBM SPSS Statistics Version 20 ). Results There was significant difference for the distribution of genotypes in SNP rs4652 between the cases and control subjects ( P = 0. 046). Through the stratification of gender, there was significant difference for the distribution of genotypes in SNP rs4652 between cases and control subjects in female ( additive model, CC/AC/AA, P = 0. 020 ; dominant model, CC + AC/AA, P = 0. 009 ). Subjects with CC and AC genotypes were more susceptible to skull base chordomas ( OR = 4. 5;95% CI = 1. 365 - 14. 833). There was no difference in the distribution of genotypes and alleles at galectin - 3 gene rs4644 between cases and control subjects ( P 〉 0.05 ). Conclusions The SNP rs4652 in Galectin - 3 gene might be associated with the susceptibility of skull base chordomas in female. In female, persons carrying CC or AC genotype might have an increased risk for skull base chordomas.
出处 《中华神经外科杂志》 CSCD 北大核心 2014年第6期568-571,共4页 Chinese Journal of Neurosurgery
基金 国家自然科学基金(81101910)
关键词 颅底 脊索瘤 GALECTIN-3 基因多态性 Skull base Chordoma Galectin - 3 Single nucleotide polymorphisms
  • 相关文献

参考文献23

  • 1Kendall BE. Cranial chordomas[J]. Br J Radiol, 1977,50: 687 -698.
  • 2MemasterML, GoldsteinAM, BromleyCM, etal. Chordoma: incidence and survival patterns in the United States, 1973-1995 [ J ]. Cancer Causes Control,2001,12 : 1-11.
  • 3Higinbotham NL, Phillips RF, Farr HW, et al. Chordoma. Thirty-five-year study at Memorial Hospital [ J]. Cancer, 1967, 20 : 1841-1850.
  • 4Raz A, Memmsky L, Zvibel I, et al. Transformation-related changes in the expression of endogenous cell lectins [ J ]. Int J Cancer, 1987,39 : 353 -360.
  • 5Roff CF, Wang JL. Endogenous lectins from cultured ceils. Isolation and characterization of carbohydrate-binding proteins from 3T3 fibroblasts[ J]. J Biol Chem, 1983,258 : 10657-10663.
  • 6Ho MK, Springer TA. Mac-2, a novel 32,000 Mr mouse macrephage subpopulation-specific antigen defined by monoclonal antibodies [ J ]. J Immunol, 1982,128 : 1221-1228.
  • 7Cerra RF, Girt MA, Barondes SH. Three soluble rat beta- galactoside-binding leetins [ J ] . J Biol Chem, 1985, 260: 10474-10477.
  • 8Barondes SH, Castronovo V, Cooper DN, et al. Galeetins : a family of animal beta-galaetoside-binding leetins[ J]. Cell,1994, 76:597-598.
  • 9Raimond J, Zimonjie DB, Mignon C, et al. Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22 [ J ]. Mamm Genome, 1997,8:706-707.
  • 10Kadrofske MM, Openo KP, Wang JL. The human LGALS3 (galeetin-3) gene: determination of the gene structure and functional characterization of the promoter [ J ]. Arch Bioehem Biophys, 1998,349:7-20.

二级参考文献16

  • 1张俊廷,王亮,吴震,贾桂军,张力伟.颅底脊索瘤患者生存因素分析[J].中华医学杂志,2007,87(23):1607-1610. 被引量:7
  • 2吴震,张俊廷,张力伟,贾桂军,王亮.颅底脊索瘤的长期随访研究[J].中华外科杂志,2007,45(16):1118-1120. 被引量:7
  • 3Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notoebordaldevelopment, is a novel biomarker for ehordomas. J Patho1,2006,209 : 157-165.
  • 4Mcmaster ML, Goldstein AM, Bromley CM, et al. Chordoma: inc- idence and survival patterns in the United States, 1973- 1995. Cancer Causes Control ,2001,12 : 1-11.
  • 5Feigl GC, Bundschuh O, Gharabaghi A, et al. Evaluation of a new concept for the management of skull basechordomas and chondrosareomas. J Neurosurg,2005,102 Suppl: 165-170.
  • 6Wu Z, Zhang J, Zhang L, et al. Prognostic factors for long-term outcome of patients with surgical resection of skull basechordomas-106 cases review in one institution. Neurosurg Rev, 2010,33:451-456.
  • 7Samii A, Gerganov VM, Herold C, et al. Chordomas of the skull base : surgical management and outcome. J Neurosurg,2007,107 : 319-324.
  • 8Romeo S, Hogendoom PC. Brachyury and chordoma: the ehondr- oid-chordoid dilemma resolved? . J Patho1,2006,209:143-146.
  • 9ShenJ, Li CD, Yang HL, et al. Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of braehyury and galeetin- 3. J Clin Neurosci,2011,18:96-99.
  • 10Oakley GJ, Fuhrer K, Seethala RR. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vschondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol,2008,21:1461-1469.

共引文献1

同被引文献23

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部